Cargando…

Legumain Promotes Atherosclerotic Vascular Remodeling

Legumain, a recently discovered cysteine protease, is increased in both carotid plaques and plasma of patients with carotid atherosclerosis. Legumain increases the migration of human monocytes and human umbilical vein endothelial cells (HUVECs). However, the causal relationship between legumain and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozawa, Nana, Sato, Yuki, Mori, Yukari, Masuda, Hiroko, Yamane, Mao, Yamamoto, Yuka, Shirai, Remina, Watanabe, Rena, Sato, Kengo, Mori, Yusaku, Hirano, Tsutomu, Watanabe, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539540/
https://www.ncbi.nlm.nih.gov/pubmed/31060209
http://dx.doi.org/10.3390/ijms20092195
_version_ 1783422413391790080
author Ozawa, Nana
Sato, Yuki
Mori, Yukari
Masuda, Hiroko
Yamane, Mao
Yamamoto, Yuka
Shirai, Remina
Watanabe, Rena
Sato, Kengo
Mori, Yusaku
Hirano, Tsutomu
Watanabe, Takuya
author_facet Ozawa, Nana
Sato, Yuki
Mori, Yukari
Masuda, Hiroko
Yamane, Mao
Yamamoto, Yuka
Shirai, Remina
Watanabe, Rena
Sato, Kengo
Mori, Yusaku
Hirano, Tsutomu
Watanabe, Takuya
author_sort Ozawa, Nana
collection PubMed
description Legumain, a recently discovered cysteine protease, is increased in both carotid plaques and plasma of patients with carotid atherosclerosis. Legumain increases the migration of human monocytes and human umbilical vein endothelial cells (HUVECs). However, the causal relationship between legumain and atherosclerosis formation is not clear. We assessed the expression of legumain in aortic atheromatous plaques and after wire-injury-induced femoral artery neointimal thickening and investigated the effect of chronic legumain infusion on atherogenesis in Apoe(−/−) mice. We also investigated the associated cellular and molecular mechanisms in vitro, by assessing the effects of legumain on inflammatory responses in HUVECs and THP-1 monocyte-derived macrophages; macrophage foam cell formation; and migration, proliferation, and extracellular matrix protein expression in human aortic smooth muscle cells (HASMCs). Legumain was expressed at high levels in atheromatous plaques and wire injury-induced neointimal lesions in Apoe(−/−) mice. Legumain was also expressed abundantly in THP-1 monocytes, THP-1 monocyte-derived macrophages, HASMCs, and HUVECs. Legumain suppressed lipopolysaccharide-induced mRNA expression of vascular cell adhesion molecule-1 (VCAM1), but potentiated the expression of interleukin-6 (IL6) and E-selectin (SELE) in HUVECs. Legumain enhanced the inflammatory M1 phenotype and oxidized low-density lipoprotein-induced foam cell formation in macrophages. Legumain did not alter the proliferation or apoptosis of HASMCs, but it increased their migration. Moreover, legumain increased the expression of collagen-3, fibronectin, and elastin, but not collagen-1, in HASMCs. Chronic infusion of legumain into Apoe(−/−) mice potentiated the development of atherosclerotic lesions, accompanied by vascular remodeling, an increase in the number of macrophages and ASMCs, and increased collagen-3 expression in plaques. Our study provides the first evidence that legumain contributes to the induction of atherosclerotic vascular remodeling.
format Online
Article
Text
id pubmed-6539540
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65395402019-06-04 Legumain Promotes Atherosclerotic Vascular Remodeling Ozawa, Nana Sato, Yuki Mori, Yukari Masuda, Hiroko Yamane, Mao Yamamoto, Yuka Shirai, Remina Watanabe, Rena Sato, Kengo Mori, Yusaku Hirano, Tsutomu Watanabe, Takuya Int J Mol Sci Article Legumain, a recently discovered cysteine protease, is increased in both carotid plaques and plasma of patients with carotid atherosclerosis. Legumain increases the migration of human monocytes and human umbilical vein endothelial cells (HUVECs). However, the causal relationship between legumain and atherosclerosis formation is not clear. We assessed the expression of legumain in aortic atheromatous plaques and after wire-injury-induced femoral artery neointimal thickening and investigated the effect of chronic legumain infusion on atherogenesis in Apoe(−/−) mice. We also investigated the associated cellular and molecular mechanisms in vitro, by assessing the effects of legumain on inflammatory responses in HUVECs and THP-1 monocyte-derived macrophages; macrophage foam cell formation; and migration, proliferation, and extracellular matrix protein expression in human aortic smooth muscle cells (HASMCs). Legumain was expressed at high levels in atheromatous plaques and wire injury-induced neointimal lesions in Apoe(−/−) mice. Legumain was also expressed abundantly in THP-1 monocytes, THP-1 monocyte-derived macrophages, HASMCs, and HUVECs. Legumain suppressed lipopolysaccharide-induced mRNA expression of vascular cell adhesion molecule-1 (VCAM1), but potentiated the expression of interleukin-6 (IL6) and E-selectin (SELE) in HUVECs. Legumain enhanced the inflammatory M1 phenotype and oxidized low-density lipoprotein-induced foam cell formation in macrophages. Legumain did not alter the proliferation or apoptosis of HASMCs, but it increased their migration. Moreover, legumain increased the expression of collagen-3, fibronectin, and elastin, but not collagen-1, in HASMCs. Chronic infusion of legumain into Apoe(−/−) mice potentiated the development of atherosclerotic lesions, accompanied by vascular remodeling, an increase in the number of macrophages and ASMCs, and increased collagen-3 expression in plaques. Our study provides the first evidence that legumain contributes to the induction of atherosclerotic vascular remodeling. MDPI 2019-05-04 /pmc/articles/PMC6539540/ /pubmed/31060209 http://dx.doi.org/10.3390/ijms20092195 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ozawa, Nana
Sato, Yuki
Mori, Yukari
Masuda, Hiroko
Yamane, Mao
Yamamoto, Yuka
Shirai, Remina
Watanabe, Rena
Sato, Kengo
Mori, Yusaku
Hirano, Tsutomu
Watanabe, Takuya
Legumain Promotes Atherosclerotic Vascular Remodeling
title Legumain Promotes Atherosclerotic Vascular Remodeling
title_full Legumain Promotes Atherosclerotic Vascular Remodeling
title_fullStr Legumain Promotes Atherosclerotic Vascular Remodeling
title_full_unstemmed Legumain Promotes Atherosclerotic Vascular Remodeling
title_short Legumain Promotes Atherosclerotic Vascular Remodeling
title_sort legumain promotes atherosclerotic vascular remodeling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539540/
https://www.ncbi.nlm.nih.gov/pubmed/31060209
http://dx.doi.org/10.3390/ijms20092195
work_keys_str_mv AT ozawanana legumainpromotesatheroscleroticvascularremodeling
AT satoyuki legumainpromotesatheroscleroticvascularremodeling
AT moriyukari legumainpromotesatheroscleroticvascularremodeling
AT masudahiroko legumainpromotesatheroscleroticvascularremodeling
AT yamanemao legumainpromotesatheroscleroticvascularremodeling
AT yamamotoyuka legumainpromotesatheroscleroticvascularremodeling
AT shirairemina legumainpromotesatheroscleroticvascularremodeling
AT watanaberena legumainpromotesatheroscleroticvascularremodeling
AT satokengo legumainpromotesatheroscleroticvascularremodeling
AT moriyusaku legumainpromotesatheroscleroticvascularremodeling
AT hiranotsutomu legumainpromotesatheroscleroticvascularremodeling
AT watanabetakuya legumainpromotesatheroscleroticvascularremodeling